Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis

Published:2023-09-29 Issue:10 Volume:43 Page:4303-4313
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

PETRELLI FAUSTO,REA CARMEN,PARATI MARIA CHIARA,BORGONOVO KAREN,GHILARDI MARA,DOTTORINI LORENZO,LUCIANI ANDREA,GHIDINI MICHELE,RUATTA FIORELLA,GARRONE ORNELLA,TOMASELLO GIANLUCA

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast;Clinical Breast Cancer;2024-08

2. Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy;Oncology and Therapy;2024-06-28

3. The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study;Breast Cancer Research and Treatment;2024-05-14

4. HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity;Oncotarget;2024-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP